GE HealthCare Technologies (GEHC) Receivables - Other (2022 - 2026)

GE HealthCare Technologies has reported Receivables - Other for 5 years, with the latest figure at $715.0 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other rose 25.0% year-over-year to $715.0 million; the trailing twelve-month figure through Mar 2026 stood at $715.0 million (up 25.0% YoY), and the FY2025 full-year result was $645.0 million, up 124.74% from the prior year.
• Receivables - Other for Q1 2026 stood at $715.0 million, up from $645.0 million in the prior quarter.
• The five-year high for Receivables - Other was $715.0 million in Q1 2026, with the low at $257.0 million in Q3 2024.
• Historically, Receivables - Other has averaged $504.1 million across 5 years, with a median of $580.5 million in 2022.
• Annual changes were most pronounced in 2024 — Receivables - Other slumped 52.17% — and 2025, when it soared 124.74%.
• GE HealthCare Technologies' Receivables - Other stood at $584.0 million in 2022, then advanced by 2.74% to $600.0 million in 2023, then sank by 52.17% to $287.0 million in 2024, then soared by 124.74% to $645.0 million in 2025, then advanced by 10.85% to $715.0 million in 2026.
• The last three Receivables - Other figures came in at $715.0 million (Q1 2026), $645.0 million (Q4 2025), and $368.0 million (Q3 2025), per Business Quant data.